肺段切除术和肺楔形切除术治疗直径≤2cm的外周性肺腺癌围手术期效果分析

doi:10.3969/j.issn.1005-6483.2021.11.014

摘要/Abstract

摘要： 目的比较肺段切除术和肺楔形切除术在直径≤2cm且CT显示结节≥50%表现为磨玻璃样的肺腺癌治疗效果。
方法 2020年1月～2021年7我院行肺段切除术或肺楔形切除术的肺腺癌病人38例，根据治疗方法分为两组，段切组16例，采用肺段切除术；楔切组22例，采用肺楔形切除术，比较两组手术相关指标。
结果两组均无围术期死亡病例。段切组和楔切组手术时间分别为(131.6±40.2)分钟和(20.3±10.2)分钟，术中失血量分别为(67.2±49.1)ml和(9.9±5.1)ml,引流管拔管时间分别为(3.5±1.5)天和(1.5±0.5)天, 住院时间分别为(4.5±3.5)天和(2.5±1.5)天，两组比较差异有统计学意义(P＜0.05)。楔切组优于段切组。
结论对于外周性(肺实质外1/3) 且直径≤2cm的早期肺腺癌，肺楔形切除优于肺段切除。

关键词: 肺癌, 肺段切除术, 楔形切除术

Abstract: Objective To compare the therapeutic effects of segmentectomy and lung wedge resection for lung cancer with a diameter ≤ 2cm and CT shows that ground glass nodules ≥ 50%.
Methods From January 2020 to July 2021,38 patients with lung adenocarcinoma who underwent segmental resection or pulmonary wedge resection at Zhongnan Hospital of Wuhan University were enrolled.Among them:16 cases in the segmental resection group(segmental resection group);22 cases in the wedge resection group(wedge resection group),compared the clinical data of the two groups of patients.
Results There was no perioperative death in both groups.Operation time [(131.6±40.2)min vs.(20.3±10.2) min],intraoperative blood loss [(67.2±49.1) ml vs.(9.9±5.1) ml],drainage tube extubation time[(3.5±1.5)d vs.(1.5±0.5)d] and hospitalization time [(4.5±3.5)d vs.(2.5±1.5)d] in the segmental resection group and the wedge resection group were statistically significant(P＜0.05).All these aspects,resection the wedge resection group was significantly better than the segment resection group.
Conclusion Pulmonary wedge resection is beneficial to the rapid recovery of patients with peripheral(1/3 of outside the lung parenchyma) and pulmonary adenocarcinoma with diameter ≤2cm.

Key words: lung cancer, segmentectomy, wedge resection

王现国刘俊. 肺段切除术和肺楔形切除术治疗直径≤2cm的外周性肺腺癌围手术期效果分析[J]. 临床外科杂志, 2021, 29(11): 1044-1046.

WANG Xianguo, LIU Jun.. A retrospective study of segmentectomy and wedge resection in the treatment of peripheral lung cancer with a diameter of ≤2cm[J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(11): 1044-1046.

参考文献

相关文章 15

[1]	刘晓军韩笑王盼李建华蓝新颜. 3D-CT影像技术在胸腔镜肺手术中的应用[J]. 临床外科杂志, 2021, 29(9): 830-833.
[2]	周存荣, 黄陈军, 蔡强. Flex三维胸腔镜肺叶切除及淋巴结清扫术治疗原发性肺癌的疗效及安全性分析[J]. 临床外科杂志, 2021, 29(8): 717-720.
[3]	吴文博, 张霄鹏, 薛文飞等. 胸部CT平扫三维重建与增强扫描〖JP2〗三维重建技术在解剖性肺段切除中〖JP〗的应用分析[J]. 临床外科杂志, 2021, 29(8): 730-734.
[4]	郑衍洪梁柱马炳太黄厚沐. 左侧肺癌切除联合区域淋巴结清扫手术病人淋巴结转移与临床病理的关系分析[J]. 临床外科杂志, 2021, 29(5): 463-465.
[5]	万志华吴瑞锋刘伟明蔡艳刘博于宁姚轶超. 3D胸腔镜肺叶切除术治疗原发性肺癌的疗效分析[J]. 临床外科杂志, 2021, 29(3): 269-272.
[6]	陈宇, 方汉林, 刘闻. 全胸腔镜手术对肺癌病人的肿瘤标志物神经元特异烯醇化酶、降钙素原、CD3+、CD4+和CD8+的影响[J]. 临床外科杂志, 2021, 29(2): 140-142.
[7]	孙临奥李昌盛周雪峰. 甘氨酸甲基转移酶在肺癌及癌旁组织中的表达及临床意义[J]. 临床外科杂志, 2021, 29(10): 945-948.
[8]	拜都如拉·艾尼吐凯撒尔·吾甫尔付毅常炜车勇. 肺叶切除术和亚肺叶切除对老年早期非小细胞肺癌病人肺功能和术后复发的影响[J]. 临床外科杂志, 2021, 29(10): 949-952.
[9]	冯浩洁姚颐耿庆. 美国国家综合癌症网络临床实践指南：非小细胞肺癌(2021V1)更新解读[J]. 临床外科杂志, 2021, 29(1): 25-28.
[10]	周超李文涛王瑞方文涛. 双镜联合治疗同时性多原发肺癌13例临床分析[J]. 临床外科杂志, 2021, 29(1): 38-41.
[11]	黎增亮潘宴青马国栋. 实性影/占位总径比率在肺多发性磨玻璃样结节术后的预后价值[J]. 临床外科杂志, 2020, 28(9): 841-844.
[12]	袁野金润森李鹤成. 机器人手术在肺癌外科的现状和展望[J]. 临床外科杂志, 2020, 28(7): 601-604.
[13]	李宗元陈晓烨刘伦旭. 机器学习在肺癌外科的研究进展[J]. 临床外科杂志, 2020, 28(7): 605-607.
[14]	滕啸胡坚. 非小细胞肺癌新辅助免疫治疗前景[J]. 临床外科杂志, 2020, 28(7): 608-610.
[15]	张帆谭锋维薛奇高树庚. 免疫检查点抑制剂在非小细胞肺癌新辅助治疗中的现状[J]. 临床外科杂志, 2020, 28(7): 611-614.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed